- Home
- PPBI vs CNTA Comparison
PPBI vs CNTA Comparison
Compare PPBI & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBI
- CNTA
- Stock Information
- Founded
- PPBI 1983
- CNTA 2020
- Country
- PPBI United States
- CNTA United Kingdom
- Employees
- PPBI N/A
- CNTA N/A
- Industry
- PPBI Major Banks
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- PPBI Finance
- CNTA Health Care
- Exchange
- PPBI Nasdaq
- CNTA Nasdaq
- Market Cap
- PPBI 2.5B
- CNTA 2.2B
- IPO Year
- PPBI 1997
- CNTA 2021
- Fundamental
- Price
- PPBI $27.75
- CNTA $16.00
- Analyst Decision
- PPBI Buy
- CNTA Strong Buy
- Analyst Count
- PPBI 6
- CNTA 7
- Target Price
- PPBI $26.50
- CNTA $23.71
- AVG Volume (30 Days)
- PPBI 587.4K
- CNTA 463.7K
- Earning Date
- PPBI 10-24-2024
- CNTA 11-12-2024
- Dividend Yield
- PPBI 4.76%
- CNTA N/A
- EPS Growth
- PPBI N/A
- CNTA N/A
- EPS
- PPBI N/A
- CNTA N/A
- Revenue
- PPBI $379,785,000.00
- CNTA $6,853,000.00
- Revenue This Year
- PPBI N/A
- CNTA N/A
- Revenue Next Year
- PPBI N/A
- CNTA N/A
- P/E Ratio
- PPBI N/A
- CNTA N/A
- Revenue Growth
- PPBI N/A
- CNTA N/A
- 52 Week Low
- PPBI $20.52
- CNTA $5.58
- 52 Week High
- PPBI $30.13
- CNTA $18.74
- Technical
- Relative Strength Index (RSI)
- PPBI 57.46
- CNTA 49.07
- Support Level
- PPBI $24.43
- CNTA $15.15
- Resistance Level
- PPBI $29.01
- CNTA $18.74
- Average True Range (ATR)
- PPBI 0.90
- CNTA 0.88
- MACD
- PPBI 0.12
- CNTA 0.10
- Stochastic Oscillator
- PPBI 63.72
- CNTA 35.68
About PPBI Pacific Premier Bancorp Inc
Pacific Premier Bancorp Inc through its subsidiaries, provides banking products and services. It offers cash management, electronic banking services, credit facilities, and retirement accounts, among others.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.